跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 5,050 条关于
“HXN-1003”
全部
5,050
临床试验
3,707
药物
930
机构
8
资讯
405
3天前
Earendil Labs and Genentech Sign Bispecific Antibody Collaboration Worth More Than $1.5 Billion
5个月前
Earendil Labs Initiates Phase IIa Trial of Half-Life Extended Anti-TL1A Antibody HXN-1001 for Ulcerative Colitis
11个月前
Sarepta Advances SRP-1003 siRNA Therapy for Myotonic Dystrophy Type 1 with Positive Safety Review
11个月前
AskBio Reports Positive Interim Safety Data for AB-1003 Gene Therapy in Rare Muscular Dystrophy Trial
去年
AskBio's AB-1003 Receives FDA Rare Pediatric Disease and Orphan Drug Designations for LGMD2I/R9
去年
AskBio's AB-1003 Receives FDA Designations for LGMD2I/R9 Treatment
去年
AskBio Advances Phase 1/2 Gene Therapy Trial for Rare Muscular Dystrophy with Second Cohort Dosing
去年
Zydus Lifesciences Advances Two Drug Development Programs with CDSCO Regulatory Approvals
去年
Renal Denervation Shows Promise in Managing Hypertension Variability
9个月前
AskBio's Gene Therapies AB-1005 and AB-1002 Receive Japan's Pioneering Regenerative Medical Product Designation
第 1 页,共 41 页
上一页
下一页